Pregnancy

Published on 02/03/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1159 times

76

Pregnancy

Maternal physiology

Maternal physiology changes so dramatically during pregnancy that reference intervals for biochemical tests in non-pregnant women are often not applicable. The main differences in commonly requested tests are shown in Table 76.1. These differences should not be misinterpreted as indicating that some pathology is present.

Table 76.1

Reference intervals in the third trimester of pregnancy, and how they compare with non-pregnant controls

Serum/blood measurement Pregnant Non-pregnant
Potassium (mmol/L) 3.2–4.6 3.5–5.3
Chloride (mmol/L) 97–107 95–108
Bicarbonate (mmol/L) 18–28 22–29
Urea (mmol/L) 1.0–3.8 2.5–7.8
Glucose (fasting) (mmol/L) 3.0–5.0 4.0–5.5
Adjusted Calcium (mmol/L) 2.2–2.8 2.2–2.6
Magnesium (mmol/L) 0.6–0.8 0.7–1.0
Albumin (g/L) 32–42 35–50
Bilirubin (µmol/L) <15 <21
Alanine aminotransferase (U/L) 3–28 3–55
Aspartate aminotransferase (U/L) 3–31 12–48
Alkaline phosphatase (U/L) 174–400 30–130
Blood H+ (nmol/L) 34–50 35–45
Blood PCO2 (kPa) 3.0–5.0 4.4–5.6

Pregnancy-associated pathology

Morbidity during pregnancy may be due to pre-existing medical conditions in the mother such as diabetes mellitus, hypertension, renal disease, thyrotoxicosis, or due to pregnancy-associated conditions.

Gestational diabetes

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. This definition applies irrespective of treatment modality used and whether or not the condition persists after pregnancy. It recognizes the possibility that unrecognized glucose intolerance may have antedated or begun concomitantly with the pregnancy. Depending on the population studies, the prevalence of GDM may be as high as 10% of all pregnancies. Maternal glycaemic status should be rechecked 6 weeks after delivery; women with GDM are at increased risk of developing diabetes, usually type 2, after pregnancy. Maternal hyperglycaemia promotes hyperinsulinism in the fetus (Fig 76.1). Insulin in a growth factor, and babies of poorly controlled diabetic patients are large and bloated. GDM is associated with increased fetal morbidity and mortality. Tight control of diabetes during pregnancy decreases complications.

Hypertension

The patient who develops hypertension in pregnancy – a condition described variously as pre-eclampsia or pregnancy-induced hypertension – is at increased risk of placental insufficiency and consequent fetal intrauterine growth retardation. The hypertension is thought to be the causative factor of eclampsia, a severe illness that usually occurs in the second half of pregnancy and is characterized by generalized convulsions, extreme hypertension and impaired renal function including proteinuria. This disease is a significant cause of maternal death, which occurs most commonly as a result of cerebral haemorrhage. The features of pre-eclampsia are shown in Figure 76.2. There are similarities between pre-eclampsia and two other conditions seen in pregnancy – namely the HELLP syndrome (haemolysis, elevated liver enzymes and low platelets) and acute fatty liver of pregnancy. Blood-borne factors from a poorly perfused placenta may activate the maternal endothelium, causing endothelial dysfunction and vascular damage. Altered liver metabolism may also contribute, especially to acute fatty liver of pregnancy, by contributing to triglyceride accumulation in the liver. Frequently it is difficult to decide on the optimum time for delivery. Laboratory investigations may help inform this decision. These include transaminases (AST and ALT), LDH, platelet count, triglyceride and urine protein.

Obstetric cholestasis

This is a multifactorial condition of pregnancy characterized by pruritis in the absence of a skin rash, with abnormal liver function tests, neither of which has an alternative cause and both of which resolve after birth. It is likely that the high levels of circulating hormones impair normal bile flow in the gall bladder. It is more common in the third trimester, but usually subsides within a few days of delivery. Along with maternal morbidity it is also associated with fetal risks – preterm birth and intrauterine death. Known risk factors include personal or family history of cholestasis, multiple pregnancy, gallstones and hepatitis C. Although elevated serum bile acid concentration is considered a sensitive indicator of obstetric cholestasis, normal levels do not exclude the diagnosis. Other features include pale stools, dark urine, jaundice and elevated liver enzymes. Treatment is directed towards symptomatic relief and includes topical antihistamines and oral urdodeoxycholic acid; supplemental vitamin K is also prescribed. In severe cases early elective delivery may be considered.

Drugs in pregnancy

Many women have, of necessity, to continue to take drugs during pregnancy. No drugs are without risk to the developing fetus, and drug levels should be kept as low as possible during gestation and thereafter if the mother is breast feeding, since many drugs are secreted in breast milk. Of particular concern are anticonvulsant drugs. Careful monitoring of levels is necessary to steer between the dangers of maternal seizures and potential fetal damage from the drug.